About this trial
This Study aims to evaluate the efficacy of opioid free general anesthesia in achieving enhanced recovery after surgery (ERAS) in laparoscopic bariatric surgery in terms of post-operative recovery time, cumulative pethidine consumption and number of episodes of postoperative nausea and vomiting(PONV).
Eligibility criteria
Qualifiers
Undergoing a scheduled laparoscopic bariatric surgery under general anesthesia.
Age group: 18-65 years old.
BMI greater than 35 to 50 Kg/m2
ASA physical status classes I and II.
Disqualifiers
Patient refusal.
ASA physical status classes III and IV.
Anticipated difficult intubation.
Hypersensitivity to any drugs used in this study. Inability to extubate the patient at the end of the operation. Conversion to laparotomy. Patients for whom the anesthetic regimen is changed intraoperatively (from OFA to OBA or vice versa).
Trial design
Treatments tested in this trial
- Fentanyl infusion
- Dexamedomedine and ketamine infusion